{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:35:25Z","timestamp":1777480525639,"version":"3.51.4"},"reference-count":16,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2017,2,27]],"date-time":"2017-02-27T00:00:00Z","timestamp":1488153600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CBM"],"published-print":{"date-parts":[[2017,2,27]]},"DOI":"10.3233\/cbm-160281","type":"journal-article","created":{"date-parts":[[2016,12,13]],"date-time":"2016-12-13T09:44:22Z","timestamp":1481622262000},"page":"183-190","source":"Crossref","is-referenced-by-count":5,"title":["Mechanism of Bushen Jianpi decoction in preventing and treating osteoporosis caused by aromatase inhibitors in breast cancer treatment"],"prefix":"10.1177","volume":"18","author":[{"given":"Xu-Hui","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Traditional Chinese Medicine, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong-Hua","family":"Liang","sequence":"additional","affiliation":[{"name":"Guangzhou University of Chinese Medicine, Guangzhou 510403, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le","family":"Su","sequence":"additional","affiliation":[{"name":"Guangzhou University of Chinese Medicine, Guangzhou 510403, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Guo","sequence":"additional","affiliation":[{"name":"Guangzhou University of Chinese Medicine, Guangzhou 510403, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Jun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Traditional Chinese Medicine, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"issue":"8","key":"10.3233\/CBM-160281_ref1","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.6004\/jnccn.2015.0125","article-title":"Optimizing endocrine therapy for breast cancer [J]","volume":"13","author":"Zelnak","year":"2015","journal-title":"J Natl Compr Canc Netw"},{"key":"10.3233\/CBM-160281_ref2","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2147\/IJWH.S69907","article-title":"Clinical utilities of aromatase inhibitors in breast cancer [J]","volume":"7","author":"Chumsri","year":"2015","journal-title":"Int J Womens Health"},{"issue":"1","key":"10.3233\/CBM-160281_ref3","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1530\/ERC-13-0269","article-title":"Aromatase inhibitors in the breast cancer clinic: focus on exemestane [J]","volume":"21","author":"Van Asten","year":"2014","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"10.3233\/CBM-160281_ref4","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2174\/18715206113139990306","article-title":"Nonsteroidal aromatase inhibitors for the treatment of breast cancer: an update [J]","volume":"14","author":"Gobbi","year":"2014","journal-title":"Anticancer Agents Med Chem"},{"issue":"5","key":"10.3233\/CBM-160281_ref5","first-page":"810","article-title":"The clinical observation of bone mineral density and total alkaline phosphatase in long-term supplement estrogen women with ovaries removed","volume":"7","author":"Gai","year":"2003","journal-title":"Chin J Clin Rehabil"},{"issue":"19","key":"10.3233\/CBM-160281_ref6","first-page":"8","article-title":"The study of the source of alkaline phosphatase in blood of rats with osteoporosis","volume":"51","author":"Du","year":"2011","journal-title":"Shandong Medi J"},{"issue":"35","key":"10.3233\/CBM-160281_ref7","first-page":"108","article-title":"The clinical study of Bushen Jianpi Huoxue decoction in the treatment of osteoporosis","volume":"9","author":"Du","year":"2005","journal-title":"Chin J Clin Rehabil"},{"issue":"5","key":"10.3233\/CBM-160281_ref8","first-page":"574","article-title":"Sagopilone inhibits bone metastases and bone destruction in breast cancer by inhibiting tumor cell growth and bone absorption","volume":"3","author":"Ren","year":"2009","journal-title":"Chin J Breast Dis"},{"issue":"12","key":"10.3233\/CBM-160281_ref9","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1007\/s00198-008-0660-9","article-title":"Biochemical markers of bone turnover: potential use in the investigation and management of postmenopausal osteoporosis [J]","volume":"19","author":"Szulc","year":"2008","journal-title":"Osteoporos Int"},{"issue":"2","key":"10.3233\/CBM-160281_ref10","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2325\/jbcs.954","article-title":"Current clinical trials of endocrine therapy for breast cancer [J]","volume":"14","author":"Kurebayashi","year":"2007","journal-title":"Breast Cancer"},{"key":"10.3233\/CBM-160281_ref11","doi-asserted-by":"crossref","first-page":"5144","DOI":"10.1200\/JCO.2008.21.0716","article-title":"Effects of tamoxifen and raloxifene on memory and other cognitive abilities: cognition in the study of tamoxifen and raloxifene","volume":"27","author":"Legault","year":"2009","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.3233\/CBM-160281_ref12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3322\/canjclin.55.3.145","article-title":"Aromatase inhibitors as adjuvant therapy for postmenopausal patients with early stage breast cancer","volume":"55","author":"Kudachadkar","year":"2005","journal-title":"CA Caneer J Clin"},{"issue":"10","key":"10.3233\/CBM-160281_ref13","first-page":"969","article-title":"The role of estrogen receptor signaling pathways in the development and treatment of breast cancer","volume":"23","author":"Tan","year":"2011","journal-title":"Chin Bull Life Sci"},{"issue":"7","key":"10.3233\/CBM-160281_ref14","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1158\/0008-5472.CAN-05-4363","article-title":"Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors","volume":"66","author":"Creighton","year":"2006","journal-title":"Cancer Res"},{"issue":"11","key":"10.3233\/CBM-160281_ref15","doi-asserted-by":"crossref","first-page":"5105","DOI":"10.1210\/en.2003-0705","article-title":"The antiepidermal growth factor receptor agent gefitinib (ZD1839\/Iressa) improves antihormone response and prevents development of resistance in breast cancer in vitro","volume":"144","author":"Gee","year":"2003","journal-title":"Endocrinology"},{"issue":"23","key":"10.3233\/CBM-160281_ref16","first-page":"7029","article-title":"Reversal of the estrogen receptor negative phenotype in breast cancer and rest oration of anti-estrogen response","volume":"13","author":"Bayliss","year":"2007","journal-title":"Lincancer Res"}],"container-title":["Cancer Biomarkers"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/CBM-160281","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:08:29Z","timestamp":1777385309000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/CBM-160281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,27]]},"references-count":16,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/cbm-160281","relation":{},"ISSN":["1574-0153","1875-8592"],"issn-type":[{"value":"1574-0153","type":"print"},{"value":"1875-8592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,27]]}}}